Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Agenus commences Phase 2 study of HerpV vaccine for treatment of genital herpes
Yahoo/Fly the on Wall
Tuesday, October 23, 2012 - 9:10am
tags:
HerpV, vaccines, genital herpes, Agenus
Johnson & Johnson: Litigation Makes This Pharma A Pass In 2013
Seeking Alpha
Tuesday, October 23, 2012 - 9:09am
tags:
JNJ
Glaxo Fund Looks for Early-Stage Alzheimer’s Detectors
Bloomberg
Tuesday, October 23, 2012 - 9:08am
tags:
GSK, Alzheimer's disease
FDA Lightens Up on Obesity Drugs
Motley Fool
Monday, October 22, 2012 - 6:12pm
tags:
FDA, obesity, Contrave, Arena Pharmaceuticals, Vivus, Orexigen
Hormone replacement therapy not recommended for disease prevention-U.S. panel
Reuters
Monday, October 22, 2012 - 6:10pm
tags:
HRT, menopause, Pfizer
Astellas launches bladder drug, aiming for a $1.9B franchise
Fierce Pharma
Monday, October 22, 2012 - 12:11pm
tags:
Astellas, Myrbetriq, overactive bladder
Bayer lung drug shows promise in pulmonary hypertension
Reuters
Monday, October 22, 2012 - 12:09pm
tags:
Bayer, PAH, Actelion, Gilead, Riociguat, Tracleer
GlaxoSmithKline says five late-stage trials meet main goal
Reuters
Monday, October 22, 2012 - 12:07pm
tags:
GSK, vaccines, Flu, QIV
Will Dendreon Surprise The Street On October 30?
Seeking Alpha
Monday, October 22, 2012 - 11:52am
tags:
Dendreon, Provenge
Celgene Third Quarter Earnings Preview
Investopedia.com
Monday, October 22, 2012 - 11:43am
tags:
Celgene, earnings
Biogen Idec Third Quarter Earnings Preview
Investopedia.com
Monday, October 22, 2012 - 11:42am
tags:
earnings, Biogen Idec
Teva Phase IIa Laquinimod trail results show positive data for Chron's
Yahoo/Fly on the Wall
Monday, October 22, 2012 - 11:41am
tags:
Chron's Disease, laquinimod, Teva
Orexigen receives dispute response from FDA
The Fly on the Wall
Monday, October 22, 2012 - 11:37am
tags:
FDA, Orexigen, Contrave
Eli Lilly's Upcoming Earnings: What You Need To Know
Motley Fool
Monday, October 22, 2012 - 11:37am
tags:
earnings, Eli Lilly
Abbott announces results from analysis of extension of Humira studies
The Fly on the Wall
Monday, October 22, 2012 - 11:32am
tags:
Humira, Abbott Labs, ulcerative colitis
Bristol-Myers Squibb Earnings Up Next
Motley Fool
Monday, October 22, 2012 - 11:30am
tags:
Bristol-Myers Squibb, earnings
[video]3 Big Events for 1 Big Pharma
Motley Fool
Monday, October 22, 2012 - 11:24am
tags:
Abbott Labs
Lilly Diabetes Medicine Meets Goal in Three Studies
Bloomberg
Monday, October 22, 2012 - 11:23am
tags:
diabetes, Eli Lilly, dulaglutide
Pfizer to Pay as Much as $700 Million for ADHD Drug
Bloomberg
Monday, October 22, 2012 - 11:02am
tags:
ADHD, Pfizer, NextWave Pharmaceuticals, Quillivant XR
United Therapeutics Could Lose The Battle For PAH Therapies
TheStreet.com
Monday, October 22, 2012 - 10:57am
tags:
United Therapeutics, PAH, Remodulin, Tyvaso, Adcirca

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.